NCT00285493

Brief Summary

Clinical trial using antibiotic treatment, namely Rulid, after onset of low back pain.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2006

Shorter than P25 for phase_1 low-back-pain

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 1, 2006

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 2, 2006

Completed
Last Updated

March 13, 2014

Status Verified

June 1, 2011

Enrollment Period

1 month

First QC Date

February 1, 2006

Last Update Submit

March 12, 2014

Conditions

Low Back Pain

Keywords

low back pain

Outcome Measures

Primary Outcomes (1)

  • protocol designed to assess or examine persons or groups in a systematic way to identify specific markers for eligibility for further evaluation

Interventions

AntibioticsDRUG

Eligibility Criteria

Age25 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Must be able to swallow tablets

You may not qualify if:

  • \- Allergy to antibiotics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Low Back Pain

Interventions

Anti-Bacterial Agents

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anti-Infective AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Study Officials

  • Bambi Alyagon, MSc

    Loewenstein Hospital

    STUDY DIRECTOR

  • Shoshana Weiler, MD

    Loewenstein Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 1, 2006

First Posted

February 2, 2006

Study Start

January 1, 2006

Primary Completion

February 1, 2006

Study Completion

February 1, 2006

Last Updated

March 13, 2014

Record last verified: 2011-06